Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients
- 24 September 2009
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 18 (8) , 943-949
Abstract
To examine the importance of possible outcomes of first-line versus repeated chemotherapy to ovarian cancer patients and to compare doctors' treatment intentions with patients' beliefs about cure. Women with newly diagnosed (74) or relapsed (48) ovarian cancer were prospectively followed over 2 years. The level of importance they ascribed to four chemotherapy outcomes and their beliefs about cure were assessed. Their doctors independently specified intent of successive treatments. Approximately half (54%) of newly diagnosed ovarian cancer patients (65% with residual disease >2 cm and 49% with no or ≤2 cm residual disease) ranked ‘tumour shrinkage (or decrease in blood levels of CA125)’ as ‘most important’ during first-line chemotherapy. Approximately two thirds (65–70%) of all women whose disease had relapsed also ranked ‘tumour shrinkage’ as ‘most important’ during repeated chemotherapy. Few women (<8%) rated symptom relief or absence of side-effects as most important. While both patients' and doctors' belief about cure decreased over successive treatments, patients grew more optimistic relative to doctors over time. Women's reports of advice by doctors about cure were consistent with doctors' stated intents for repeat chemotherapy. However, discordance between doctors' actual treatment intent and patients' beliefs about cure increased from 24% at first-line to 83% by fourth-line chemotherapy. Women prioritise tumour response as the most important outcome of chemotherapy for ovarian cancer. This priority predominates in women with residual and relapsed disease despite declining likelihood of cure. Women may still hope for a cure while acknowledging their doctor's advice that their disease is incurable.Keywords
This publication has 33 references indexed in Scilit:
- Use of Patient-Reported Outcomes in Phase III Cancer Treatment Trials: Lessons Learned and Future DirectionsJournal of Clinical Oncology, 2007
- Transforming the Death Sentence: Elements of Hope in Women With Advanced Ovarian CancerOncology Nursing Forum, 2007
- Changes in Preferences for Life-Sustaining Treatment Among Older Persons with Advanced IllnessJournal of General Internal Medicine, 2007
- Patterns and Progress in Ovarian Cancer Over 14 YearsObstetrics & Gynecology, 2006
- Illusions in advanced cancer: The effect of belief systems and attitudes on quality of lifePsycho-Oncology, 2003
- Stage at diagnosis of ovarian cancer in the United States, 1992-1997Cancer, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- The power of compassion: Truth-telling among American doctors in the care of dying patientsSocial Science & Medicine, 1993
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- Quality of life in cancer patients--an hypothesis.Journal of Medical Ethics, 1984